High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy

<p>Abstract</p> <p>Purpose</p> <p>To investigate the prognostic value of survivin expression in pretreatment specimens from patients with anal cancer treated with concurrent 5-FU and mitomycin C-based chemoradiation (CRT).</p> <p>Material and methods</p&g...

Full description

Bibliographic Details
Main Authors: Fraunholz Ingeborg, Rödel Claus, Distel Luitpold, Rave-Fränk Marget, Kohler Daniela, Falk Stefan, Rödel Franz
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Radiation Oncology
Subjects:
Survivin
Anal cancer
Molecular marker
Concurrent chemoradiotherapy
Online Access:http://www.ro-journal.com/content/7/1/88

Internet

http://www.ro-journal.com/content/7/1/88

Similar Items